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Background: An animal model for HBV that more closely approximates the disease in humans is needed. The tree
shrew (Tupaia belangeri) is closely related to primates and susceptible to HBV. We previously established that
neonatal tree shrews can be persistently infected with HBV in vivo, and here present a six year follow-up
histopathological study of these animals.
Methods: Group A consists of six tree shrews with persistent HBV infection, group B consists of three tree shrews
with suspected persistent HBV infection, while group C consists of four tree shrews free of HBV infection. Serum
and liver tissues samples were collected periodically from all animals. HBV antigen and HBV antibodies were
detected by ELISA and/or TRFIA. HBV DNA in serum and in liver biopsies was measured by FQ-PCR. Liver biopsies
were applied for general histopathologic observation and scoring, immunohistochemical detections of HBsAg and
HBcAg, and ultrastructural observation with electron microscope technique.
Results: Hydropic, fatty and eosinophilic degeneration of hepatocytes, lymphocytic infiltration and hyperplasia of
small bile ducts in the portal area were observed in group A. One animal infected with HBV for over six years
showed multiple necrotic areas which had fused to form bridging necrosis and fibrosis, and megalocytosis. The
hepatic histopathological scores of group A were higher than those of group B and C. The histopathological score
correlated positively with the duration of infection.
Conclusions: Hepatic histopathological changes observed in chronically HBV-infected tree shrews are similar to
those observed in HBV-infected humans. The tree shrew may represent a novel animal model for HBV infection.
Keywords: Tree shrew (Tupaia), Hepatitis B virus, Histopathological changeBackground
Hepatitis B virus (HBV) infection is a global health
problem. At least 2 billion people, one third of the
world’s population, are currently infected with HBV
worldwide, including 30 million people in China [1,2].
About 6% of the world’s population (378 million) are
chronic carriers of HBV, and approximately 1 million
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reproduction in any medium, provided the orcirrhosis and hepatocellular carcinoma (HCC) arising
from HBV infection [1]. Although a prophylactic vaccine
against HBV is currently available [3], the efficacy is lim-
ited within individuals previously infected with HBV.
This immunization regimen does not prevent HBV car-
riers from developing HCC and other end-stage liver
diseases. Improvements in our understanding of the
mechanisms underlying HBV persistence in vivo may
lead to new approaches for treating chronic hepatitis B
or preventing infection from progressing to life-
threatening lesions. A suitable animal model of persist-
ent HBV-infection, is thus in urgent demand.
HBV infection is almost entirely limited to human and
chimpanzee providing an obstacle to the establishmentd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Tree shrews assigned to groups based on HBV
infection status
Group Experimental no. Gender Age(weeks)
Weeks after
inoculation
A (n = 6)
A1 ♀ 324 324
A2 ♂ 89 89
A3 ♀ 275 275
A4 ♂ 221 221
A5 ♂ 149 149
A6 ♂ 218 218
B (n = 3)
B1 ♀ 229 229
B2 ♀ 221 221
B3 ♀ 171 171
C (n = 4)
C1 ♂ 79 -
C2 ♂ 79 -
C3 ♂ 64 -
C4 ♂ 64 -
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have been pursued, including woodchuck, ground squir-
rel or Peking duck hepadnavirus infections; however the
hepatic pathogenesis mediated by these viruses is not
equivalent to human infection with HBV [4,5]. The
chimpanzee model of HBV infection is useful, but as an
experimental subject, it is relatively rare, expensive and
inconvenient to manage.
The Tree shrew (Tupaia) is phylogenetically much
more closely related to humans [6,7], and is susceptible
to a variety of human viruses [8,9]. Walter et al. have
successfully infected tree shrew extracorporeal hepato-
cytes with HBV, and established replication of HBV in
these hepatocytes [10-12]. Our previous studies sug-
gested that persistent HBV infection can be established
in neonatal tree shrews [13,14]. Continuing observation
of those HBV-infected tree shrews for several years may
illuminate the nature of the infection. In this study, we




The criteria based on which “confirmed chronic-
infection” and “suspected chronic-infection” were de-
fined have been previously described [14]. “Confirmed
chronic infection” indicates infection of animals in
which serum HBsAg is detectable throughout the
48 weeks after inoculation, in addition to that HBV
DNA tests positive in either serum or liver biopsies.
“Suspected chronic infection” indicates infection of ani-
mals in which two of the previously described markers
are detectable on at least two occasions within the
48 weeks after inoculation.
According to the HBV infection status, the tree shrews
were divided into three groups: group A consists of six
animals that were confirmed as chronically infected;
group B consists of three animals that were suspected to
be chronically infected, while group C consists of four
normal animals that were not inoculated with HBV.
Table 1 describes the general information of the tree
shrews used in this study.
Markers of HBV infection in inoculated tree shrews
As described in Table 2, the tree shrews assigned to
group A were serum HBsAg-positive until the last in-
spection (1.7-6.2 years after inoculation). The sera ob-
tained from four of these animals were simultaneously
HBeAg and HBcAb positive, and two animals tested
HBeAb and HBcAb positive simultaneously. Within
group B, the serum of one animal tested weakly positive
for HBsAg and two tested positive for HBeAb, while all
the three animals in this group were serum HBcAb- and
HBsAb-positive simultaneously. All samples from thefour animals within group C tested negative for all the
HBV-markers mentioned above.
The results of HBV DNA determination in serum and
in liver biopsies are shown in Table 3. Among the six an-
imals in group A, the copy number of HBV DNA in
serum of five animals was above 103. The copy number
of HBV DNA in the liver tissues of group A animals
were significantly higher than that of group B (P = 0.039)
and group C animals (P = 0.011), while the difference in
copy number between group B and group C is not statis-
tically significant (P = 0.400).
Immunohistochemical staining of liver biopsies revealed
a pattern of sporadically or focally distributed HBsAg-
positive hepatocytes within all six animals in group A.
HBsAg-positive cells were distributed predominantly
around central veins, manifesting as yellowish-brown gran-
ules located mainly in the cytoplasm (Figure 1A). In all an-
imals except one (83.3%) we detected HBcAg-positive
hepatocytes. The HBcAg-positive hepatocytes contained
yellowish-brown granules, mainly located in the nuclei but
also observed in the cytoplasm (Figure 1B). All the liver bi-
opsies from animals in group B and group C tested nega-
tive for HBsAg and HBcAg staining.
Histopathological examination of the liver
All animals in group A showed liver tissue injury at dif-
ferent degrees, characterized by sporadically or diffusely
distributed hepatocellular hydropic degeneration, fatty
degeneration and acidophilic degeneration. Hepatocytes
undergoing acidophilic degeneration were sporadically
distributed, characterized by reduced cell size and con-
centrated appearance, with strengthened cytoplasmic
acidophilia and small and dark nuclei. TUNEL staining
Table 2 HBV immunological markers in tree shrew serum samplesa
Group Experimental no. HBsAga HBsAb HBeAg HBeAb HBcAb HBsAga (ng/ml)
A (n = 6)
A1 + - + - + 450.6
A2 + - - + + 797.85
A3 + - + - + 704.57
A4 + - + - + 615.88
A5 ± - - ± + 0.95
A6 + - + - + 711.14
B (n = 3)
B1 ± + - - + 0.03
B2 - + - + ± 0
B3 - + - + + 0
C (n = 4)
C1 - - - - - 0
C2 - - - - - 0
C3 - - - - - 0
C4 - - - - - 0
aThe results detected by ELISA were expressed as “+” (positive), “-” (negative) or “±” (between positive and negative), while by TRFIA were expressed as ng/ml.
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(Figure 2A). Round and red-stained small bodies without
nuclei, so called “acidophilic bodies”, were sometimes
observed among these cells. The hepatocytes undergoing
hydropic degeneration were pale, with enlarged size and
sparse cytoplasm containing fine granules. The cyto-
plasm of the hepatocytes with severe swelling was lighter
in color and even almost transparent, termed “balloon-
ing degeneration” (Figure 2B). In addition we observed
scattered or focally distributed ground-glass hepatocytes,
the cytoplasm of which contained obviously acidophilic




A (n = 6)
A1 2.63 × 106
A2 5.22 × 103
A3 8.74 × 106
A4 1.09 × 106
A5* -
A6 2.42 × 105









aHBV DNA copy number ≥103 in serum is defined as a positive; bHBV DNA copy nu
mean ± SD; dCompared with group A; eCompared with group C.
*: This animal had showed 1.1 × 107 copies/ml in serum, 3.73 × 105 and 1.82 × 108 cglass-like (Figure 2C). Serial sections of these samples
were stained immunohistochemically, demonstrating that
ground-glass hepatocytes were HBsAg-positive (Figure 2D).
Additional histopathologic changes were also observed,
including focal hepatocellular necrosis, lymphocytic infil-
tration dominated by CD3-positive (rather than PAX5-
positive) T-lymphocytes, with formation of lymphoid folli-
cles and biliary proliferation in portal areas (Figure 2E).
Aside from minor degeneration of a minority of hepato-
cytes, no obvious histopathological changes were observed
in the liver biopsies from the animals in both groups B
and C (Figure 2F).issue samples
HBV DNA in liver
Copies/μg liver DNAb Copiesc P-value






9.58 × 105 3.56 ± 5.22 × 105 0.039d
0.400b
3.91 × 104 0.400e
7.04 × 104




mber ≥105 in liver tissue is defined as a positive; cResults are shown as
opies/μg in liver at the time points of 60- and 72-Weeks after inoculation.
Figure 1 Immunohistochemical detection of HBV markers in liver. A. Immunohistochemical staining highlighting the presence of HBs
antigen within the cytoplasm of some hepatocytes, 200×. B. Immunohistochemical staining highlighting the presence of HBc antigen within the
cytoplasm and/or nucleus of some hepatocytes of some hepatocytes, 200 ×.
Ruan et al. Virology Journal 2013, 10:333 Page 4 of 11
http://www.virologyj.com/content/10/1/333The most severe histopathological changes in the liver
were found in one animal (A1) in group A who survived
the longest post-inoculation, for more than 6 years until
the end of this study. Under gross examination, the liver
of this animal was characterized by an unsmooth sur-
face, granular protuberances, yellow and red patchy le-
sions on section (Figure 3A). Microscopically, large
numbers of hepatocytes exhibited diffuse hydropic or
fatty degeneration. Binucleate or even multinucleate he-
patocytes were also observed frequently, these cells dis-
played enlarged size and a normal ratio of nucleus to
cytoplasm (Figure 3B), i.e., megalocytosis, similar to
“large cell dysplasia” observed in human patients with
chronic hepatitis B. Meanwhile, further lessons were also
observed such as confluent lytic necrosis inside lobules,
piecemeal necrosis in limiting plate areas, and structural
damage in limiting plates (Figure 3C). Confluent lytic
necrosis of hepatocytes was observed between the portal
tract and central vein and between neighboring portal
tracts, which formed bridging necrosis and bridging fi-
brosis (Figure 3D). Reticular fiber staining revealed that
the scaffolds of reticular fiber had collapsed, and that the
fibers had intertwined and surrounded hepatocytes in
the limiting plate area and formed irregular hepatocyte-
clusters that were mostly composed of survived or re-
generated hepatocytes, and were without normal lobular
architecture (Figure 3E). Masson staining revealed not-
able proliferation of collagenous fiber bundles in portal
tracts (Figure 3F).
The Liver histological status was evaluated semiquan-
titatively, according to the Knodell histology activity
index scoring system which grades necroinflammation
and fibrosis on a scale of 0 to 22, including 0 to10 for
the periportal and/or bridging necrosis, 0 to 4 for intra-
lobular degeneration and focal necrosis, 0 to 4 for portal
inflammation, and 0 to 4 for fibrosis [15].
The histopathological scores of the last liver biopsies
of the animals in each group are described in Table 4.The average score in group A, B and C was 5.33 ± 3.93,
1 and 0, respectively. The score of group A were signifi-
cantly higher than those of group B (P = 0.018) and
group C (P = 0.008), while the difference between the
scores of group B and C was not statistically significant
(P = 0.057). As shown in Figure 4, the histopathological
score was correlated significantly with the duration of
HBV infection (P = 0.000), but not with the titer of HBV
DNA in liver tissue (P = 0.159).
Hepatic ultrastructure
Transmission electron microscopy was performed on
sections of liver from animal A1 at the end of the study
and demonstrated swollen hepatocellular surface micro-
villi, variable numbers and distribution of glycogen gran-
ules in the cytoplasm and variation in size of lipid
droplets. Many mitochondria were swollen and enlarged
with vague cristae and increased electron density in the
matrix (Figure 5A). Highly electron dense rhabdoid crys-
talline inclusions were observed within the mitochondria
(Figure 5B). The endoplasmic reticulum was expanded
or formed irregular vesicles with slight degranulation,
and part of the expanded endoplasmic reticulum were
surrounded by paired membranes forming concentric la-
mellar bodies (Figure 5C). Suspected HBV granules were
distributed as clusters and had a spherical appearance,
and clear boundaries were observed in the cytoplasm
and dilated endoplasmic reticulum (Figure 5D). The
number of lysosomes increased, most of which were sec-
ondary lysosomes (Figure 5E), and some of which pos-
sessed lamellar residual bodies (myeloid bodies). Some
cell nuclei were irregular in shape and chromatin mar-
gination was observed (Figure 5F).
Discussion
Several animal models of HBV infection have been
established, including the well-tested chimpanzee model
and models utilizing alternative hepadnaviruses, but the
Figure 2 Histopathological changes in the liver of tree shrew with persistent HBV-infection. A. Hydropic degeneration, fatty degeneration
and acidophilic degeneration (arrow) in some hepatocytes. HE staining, 200×. The insert image visualizes the apoptotic cells (arrow) confirmed by
TUNEL assay. TUNEL staining, 400×. B. Ballooning degeneration in hepatocytes (arrow). HE staining, 200×. C. Ground-glass-like hepatocytes in ani-
mal A1 who was HBV-infected for more than 6 years (arrow). HE staining, 100× and 400× respectively. D. The ground-glass-like hepatocytes were
proved to be HBsAg-positive (arrow). Immunohistochemical staining for HBsAg, 100× and 400× respectively. E. Portal tracts were infiltrated with
densely packed lymphocytes (arrow), accompanied with bile duct proliferation. HE staining, 100×. The insert image visualizes the CD3-positive
lymphocytes. Immunohistochemical staining for CD3, 400×. F. Minor histopathological changes in one animal of group B. HE staining, 200 ×.
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those observed in chronic hepatitis B infection of
humans [16-18]. Previously we reported that newborn
tree shrews inoculated with HBV can develop chronic
HBV-infection, and HBV can persist and replicate
in vivo steadily for long time [14]. Subsequently, we have
found that persistent HBV infection of tree shrews can
induce histopathological changes in their liver that are
quite similar to the changes in human cases.
Chronic HBV infection of humans is generally charac-
terized as evolving in three major phases: immune toler-
ation, immune activation and inactive carrier [19].During the phase of immune tolerance, the immune sys-
tem responses weakly against the HBV-infected hepato-
cytes, which allows HBV to survive and replicate. From
this phase, most patients will progress to the phase of
immune activation, with an elevated level of HBV DNA
detected in the serum and active inflammation in liver
tissue. After HBeAg is cleared from the body and anti-
HBeAb is developed, most patients will progress to the
phase of inactive carrier, characterized mainly by low or
undetectable serum HBV DNA and reduced liver in-
flammation. The immune tolerance phase occurs more
frequently in individuals who were infected with HBV
Figure 3 Gross and histological images of tree shrew no. A1. A. The surface of the liver is coarsely nodular with multifocal mottled tan and
red areas. B. Megalocytosis. HE staining, 200× and 400× respectively. C. Piecemeal necrosis (arrow) characterized by lymphocytic infiltration
extends from portal areas and disrupts the limiting plate of hepatocytes undergoing necrosis. HE staining, 100×. D. Bridging necrosis as a streak
of hepatic necrosis extends from central vein (C) to portal tracts (P). HE staining, 40×. E. Reticular fiber collapses and intertwines to form a cluster
(arrow) in limiting plate. Gomori’s silver staining, 200× and 400× respectively. F. There is increased collagen in portal areas. Masson staining, 200×.
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cades, and the hepatic histopathological changes may be-
come more evident as the host ages [20].
Previously we reported that only minimal histopatho-
logical lesions were found in the in the liver biopsies of
these persistently HBV-infected tree shrews [14], but we
have recently found that during prolonged infection this
is not the case. This phenomenon can potentially be ex-
plained by the ability of neonatally HBV-infected tree
shrews to remain in the immune tolerant phase for lon-
ger, without obvious changes in their liver tissues. With
a longer period of observation we have found that at
least some of these animals evolved into the immune-
active phase, as the level of HBV DNA in liver tissue in-
creased along with symptoms of injury in the livertissues. The histopathological changes observed in the
liver of animal A1 six years post-inoculation highlight
the fact that conspicuous hepatic lessons can occur in
persistently HBV-infected tree shrews.
Acute and chronic HBV-infection observed in the tree
shrews in this study followed a similar course to human
hepatitis B. Acute HBV infection in human adult is usu-
ally self-limiting. Serum HBsAg can be detected for only
4 ~ 10 weeks after infection, then HBsAb is generated
and HBsAg disappears. This course of transient acute
HBV-infection has also been reported in studies of adult
tree shrews [10]. In contrast to adult tree shrews, six tree
shrews that were neonatally inoculated with HBV in this
study showed positive serum HBsAg over years. Consid-
ering the relatively short life span of the tree shrew














score Mean ± SD P-value
A (n = 6)
A1 3 4 3 3 13
5.33 ± 3.93
A2 0 1 1 0 2
A3 1 2 1 0 4
A4 1 2 1 1 5
A5 1 1 1 0 3
A6 1 2 1 1 5
B (n = 3)
B1 0 1 0 0 1 1.00 ± 0.0 0.018a
B2 0 1 0 0 1
0 0.057b
B3 0 1 0 0 1
C (n = 4)
C1 0 0 0 0 0
0.00 ± 0.00 0.008a
C2 0 0 0 0 0
C3 0 0 0 0 0
C4 0 0 0 0 0
aCompared with group A. bCompared with group C.
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markers in these animals is much longer than the estab-
lished criteria for diagnosing chronic HBV-infection in
human (6 months) [19]. Moreover, serum HBsAb was
not detected in the six tree shrews who persistently
showed HBsAg and HBV DNA in the serum and in liver,
further supporting the diagnosis of chronic HBV
infection.
A variety of pathologic changes were observed in each
of the six chronically HBV-infected tree shrews, includ-
ing hepatocellular degeneration and necrosis with mild
or moderate periportal inflammation and fibrosis. The
severity of these lesions often increased with the dur-
ation of infection. For example, significant piecemeal ne-
crosis and bridging fibrosis were observed in animal A1Figure 4 Correlation between histopathological score and
duration of HBV-infection (r = 0.808, P = 0.000).which was HBV-infected for longer than 6 years. It is
generally recognized that piecemeal necrosis is a key
milestone in progression of chronic hepatitis, and it can
be used to distinguish chronic active hepatitis from
chronic persistent hepatitis [21]. Whilst bridging fibrosis
usually results from lobular necrosis which is then re-
placed by inflammatory fibrotic tissue, the latter appears
as bridges linking the necrotic areas in portal spaces
and/or in centrilobular areas.
Megalocytosis, characterized by large, atypical and
multiple nuclei and abundant cytoplasm were also found
in animal A1. The occurrence of such cells is believed to
correlate with the risk of developing HCC [22,23]. In
addition, the majority of chronic HBV-infected tree
shrews in this study showed a relatively high level of cell
proliferation markers such as Ki67, Cyclin D1 and P53,
and HBx protein (a protein that has been associated with
HCC in humans and the woodchuck) in liver tissues in
comparison to the tree shrews without HBV infection
(data not shown). It is reasonable to speculate, therefore,
to further observation of these chronically HBV-infected
tree shrews may demonstrate that HBV can act as an in-
dependent factor for hepatocarcinogenesis. However,
compared to the carcinogenic effect of aflatoxin B1
(AFB1) alone or AFB1 plus HBV [24], the ability of HBV
to induce HCC may be relatively weak and a longer
period of infection may be required.
Additionally so-called “ground-glass” hepatocytes were
found in half of the chronic HBV-infected tree shrews
(3/6) in this study, and these cells were confirmed to be
HBsAg-positive by immunohistochemical staining. The
“ground-glass” hepatocytes are generally considered to
be those cells containing a high concentration of HBsAg,
Figure 5 Hepatocyte ultrastructure in persistent HBV infection of tree shrews under TEM. A. Mitochondria were commonly swollen and
enlarged, matrix electron density increased, and cristae were vague. M, mitochondria; N, nuclei. Osmic acid staining, 20000×. B. Electron dense
rhabdoid crystalline inclusions (arrow) in mitochondria. Osmic acid staining, 30000×. C. Endoplasmic reticulum expanded or formed irregular
vesicles with slight degranulation, and the expanded segments were surrounded by paired membranes, forming concentric lamellar bodies.
R, reticulum. Osmic acid staining, 60000×. D. Suspected HBV granules in endoplasmic reticulum (arrow). Osmic acid staining, 60000×. E. The
number of lysosomes (arrow) increased. Osmic acid staining, 20000×. F. Cell nuclei appeared irregular in shape and chromatin margination was
observed. Osmic acid staining, 20000×.
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inversely related to the activity of hepatitis [21]. With
immunohistochemical staining, both HBsAg- and
HBcAg-positive hepatocytes were detected in all chron-
ically HBV-infected tree shrews (6/6) in this study. It is
believed that the host’s immune response can eliminate
antigen-containing cells, for example HBsAg- and
HBcAg-positive hepatocytes should not be found in
acute hepatitis B [21]. The presence of HBsAg- and
HBcAg-positive hepatocytes, therefore, indicates that
these tree shrews were in the chronic rather than the
acute phase of HBV-infection. Concerning HBcAg, it is
believed that its expression in the nucleus of hepatocytesindicates HBV replication [25], while its expression in
the cytoplasm of hepatocytes indicated increased disease
severity. Chu et al. [26] reported that the patients in
whom HBcAg could be detected in both the nucleus and
cytoplasm usually experienced more severe hepatocyte
damage and higher titers of serum HBV DNA and
HBeAg. Interestingly, a similar site of HBcAg expression
in hepatocytes was observed in the tree shrews we stud-
ied. For example, there was no hepatic HBcAg expres-
sion in animal A5, who possessed low levels of HBV
DNA in the serum and in liver simultaneously; While
HBcAg expression in animal A2 was purely within the
nucleus of hepatocytes, and hepatic histopathological
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mals in group A (A1, A3, A4 and A6) expressing HBcAg
in the nucleus and cytoplasm (as showing in Figure 1B),
suffered much more obvious hepatic histopathological
changes (scored 4 or more). These findings support the
suggestion that the sites of HBcAg expression in hepato-
cytes relate to the titer of HBV DNA and the severity of
hepatic pathological changes. A potential explanation for
this observation is that the movement of HBcAg from
the nucleus to the cytoplasm triggers cellular immunity,
during which the hepatocytes with HBcAg expression
are the targets of virus-specific T cells, activating inflam-
mation in liver tissue [26].
There were significant ultrastructural findings within
the liver. For example, the changes in the mitochondria
might explain the hydropic and fatty degeneration of he-
patocytes observed under light microscopy. The in-
creased numbers of lysosomes and myeloid bodies
possibly indicated hepatocellular injury, enhancement of
autophagic activity and an increase of organelle residual
bodies. The swelling of endoplasmic reticulum was char-
acteristic of ultrastructural changes in hepatocytes in-
duced by virus infection. In addition, suspected HBV
granules with round appearance and cluster distribution
were observed in the cytoplasm and expanded endoplas-
mic reticulum in some chronic HBV-infected animals
such as A1.
Conclusions
In summary, the histopathologic changes in the livers of
tree shrews with chronic HBV infection provide further
evidence that neonatally HBV-infected tree shrews can
progress into chronic hepatitis, and both the clinical
course and the hepatic histopathological changes that
occur in these animals are fairly similar to those in hu-
man patients. The tree shrew model may provide an im-
portant tool for studying HBV-related diseases.
Materials and methods
The study protocol was approved by the Ethical Com-
mittee of Guangxi Tumor Hospital in accordance with
the guidelines issued by Chinese government, which
conforms to the ethical guidelines of the 1975 Declar-
ation of Helsinki.
Animals
Animal experiments were carried out in accordance with
the guidelines for care and use of laboratory animals is-
sued by Chinese government. The tree shrews used in
this study were descended from a population of wild tree
shrews (Tupaia belangeri chinensis) originating from the
Kunming Institute of Zoology, Chinese Academy of Sci-
ence (Yunnan, China). Offspring resulting from artificial
breeding were used in this study. The treatments ofthese animals, including HBV-inoculation and other ex-
perimental procedures, were previously described [14].
Animals were housed at the Laboratory Animal Center
of Guangxi Medical University under monitoring of
veterinarians.
Blood and tissue sample collection
Blood samples were collected once every 4~12 weeks.
The serum was tested immediately for HBV-infection
markers: HBV surface antigen (HBsAg), HBV surface
antibody (HBsAb), and HBV e antigen (HBeAg), HBV e
antibody (HBeAb) and HBV core antibody (HBcAb), as
well as HBV DNA. The remainder was stored at −80°C
before use.
Liver biopsies were performed once every 6~12 months,
under anesthesia with 1% pentobarbital and ketamine
hydrochloride. A portion of each liver biopsy was fixed
within 10% (v/v) neutral formalin and then paraffin em-
bedded for routine histopathology observation and immu-
nohistochemistry. When necessary, a portion of the biopsy
was also fixed within 2.5% glutaraldehyde at 4°C for obser-
vation under transmission electron microscopy (TEM).
The remainder of each biopsy sample was frozen immedi-
ately by immersion in liquid nitrogen then stored at −80°C
before use.
Detection of HBV directed antibodies in serum
The levels of HBV-directed antibodies present in animal
serum samples was established by ELISA (Kehua Bio-
engineering, Shanghai, China). HBsAg-positive speci-
mens were then further analyzed quantitatively by time-
resolved immunofluorescence analysis (TRFIA) (Xinbo
Biotechnology, Suzhou, China). Kits were used according
to the manufacturer’s instructions.
Detection of HBV DNA in serum and in liver
The quantity of HBV DNA in serum and in liver sam-
ples was assessed by fluorescence quantitative polymer-
ase chain reaction (FQ-PCR) (Kehua Bio-engineering
Co. Shanghai, China) according to the manufacturer’s in-
structions as previously described [14], based on the
procedures described by Lu et al. [27], or Cacciola et al.
[28] respectively. The number of copies of serum-
derived HBV DNA was calculated per ml while the liver-
derived HBV DNA was calculated per μg liver DNA,
based on the methods described by Cacciola et al. [28].
The threshold applied to classifying a tree shrew serum
sample as positive for HBV DNA was identical to that
for human samples, i.e. ≥ 103 copies/ml is defined as a
positive result by the kit’s manufacturer. While since no
critical threshold for FQ-PCR measurement of hepatic
HBV DNA has been established so far, we employed a
cut-off value of ≥105 copies/μg total liver DNA, referring
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not shown) and normal tree shrews.Histopathological and immunohistochemical analysis
Paraffin-embedded liver biopsies were stained with
hematoxylin and eosin (H&E), and Gomori’s silver and
Masson’s trichrome stains (Sinopharm Chemical Reagent
Co., Ltd., Shanghai, China) were employed to visualize
reticular and collagen fibers when necessary. All histo-
logical staining was performed in accordance with con-
ventional procedures [29]. Intrahepatic HBsAg, HBcAg,
CD3 and PAX5 were examined by Immunohistochemi-
cal assays, with the monoclonal antibodies of mouse
anti-human HBsAg, HBcAg, CD3 or PAX5 respectively
(Zhongshan Goldenbridge Biotech, Beijing, China) [13].
Apoptosis in liver tissues was detected by a terminal
deoxynucleotidyl transferase dUTP nick-end labeling
(TUNEL) assay using an In Situ Cell Death Detection
Kit (Roche, Mannheim, Germany) according to the man-
ufacturer’s instruction.Ultrastructure observation with transmission electron
microscopy (TEM)
Transmission electron microscopy (TEM) was applied to
observe the hepatic ultrastructure of animal A1 which
was persistently infected with HBV for more than 6 years.
A sample of its liver tissues obtained at the end of this
study was fixed. The tissue was dehydrated with graded
ethanol and embedded within epoxy resin (Sinopharm
Chemical Reagent Co. Ltd, Shanghai, China). The 75 nm
thick ultrathin sections were stained with methanolic ur-
anyl acetate and lead citrate, then visualized by TEM
(TECNAIG2, FEI Company, Hillsboro, Oregon, USA).Statistical analysis
Statistical analysis was conducted with SPSS 17.0 soft-
ware (IBM, Chicago, USA). Animal groups were com-
pared by non-parametric Mann–Whitney Test. The
relationship between histological scores of the animals
in group A with the duration of HBV infection, titer of
HBV DNA in liver tissue, was analyzed by Spearman’s
rank. The bilateral significance level was α = 0.05.
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